Injectable drug delivery agents consisting of polymer compounds that facilitate the delivery of pharmaceuticals via injection into the posterior chamber of the eye for the treatment of diseases and conditions, including ocular diseases, namely, uveitis and retinal disease

Injectable sustained drug delivery systems for delivering pharmaceuticals via injection into the posterior segment of the eye

Injectable pharmaceutical preparations comprising erodible ingredients that facilitate the delivery of pharmaceuticals via injection into the posterior segment of the eye for the treatment of eye diseases and conditions of the retina, namely, wet age-related macular degeneration, non-proliferative diabetic retinopathy, diabetic macular edema and retinal vein occlusion and excluding dry eye, conjunctivitis, glaucoma and bacterial eye infections